A remarkably small bacterium containing fewer than 500 genes serves as the basis for one of the most detailed digital life ...

Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...

An international research team has placed quantum light emitters onto silicon chips with roughly 90% success by using tiny ...

A Ghanaian Scientist’s breakthrough research on fluorescent molecular probes could transform how the world detects cancer at ...

Scientists have discovered a defensive method of cells that resembles Spiderman shooting his web to ensnare enemies. These cells defend our bodies from the early stages of viral infection by ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

Today is Elephant Day in Thailand!

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

A team of scientists has identified an enzyme called PurF as a new drug target for tuberculosis, offering a fresh line of ...

DeCarbon Air emphasizes that enterprise valuation in the AI and quantum era depends on protected IP, decentralized infrastructure, post-quantum security, and crisis prevention. Through Decarbon Air, ...

When bacteria cells replicate, they do so a little differently than human cells do. They don't undergo mitosis, a splitting ...